Neuronetics, Inc. · NASDAQ:STIM
Madryn Asset Management, LP reported a 30.30% stake in Neuronetics, Inc. (Schedule 13D/A)
Event Mar 2, 2026 · Filed Mar 4, 2026
Madryn Asset Management, LP reported a 30.30% stake in Neuronetics, Inc., 20,737,061 shares, with active intent on Mar 2, 2026. Filed Mar 4, 2026 (Schedule 13D/A).
- Stake
- 30.30%
- Shares
- 20,737,061
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MADRYN ASSET MANAGEMENT, LP | 30.30% | 20,737,061 |
| MADRYN HEALTH PARTNERS II, LP | 2.10% | 1,430,953 |
| MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP | 24.90% | 17,044,940 |
| MADRYN HEALTH ADVISORS II, LP | 27.00% | 18,475,893 |
| MADRYN HEALTH ADVISORS GP II, LLC | 27.00% | 18,475,893 |
| MADRYN SELECT OPPORTUNITIES, LP | 3.30% | 2,261,168 |
| MADRYN SELECT ADVISORS, LP | 3.30% | 2,261,168 |
| MADRYN SELECT ADVISORS GP, LLC | 3.30% | 2,261,168 |
Source
Related
- Neuronetics, Inc.
- Madryn Asset Management, LP
- Neuronetics, Inc. shareholders
- Schedule 13D/A · Madryn Asset Management, LP · Aug 12, 2025
- Schedule 13D/A · Chernett Jorey · Aug 24, 2026
- Form 4 · Chernett Jorey · Aug 17, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13D/A · Chernett Jorey · Aug 4, 2026
- Form 4 · Naor Nir · Jul 23, 2026